SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021191
Filing Date
2023-05-11
Accepted
2023-05-11 16:02:25
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inkt-20230331.htm   iXBRL 10-Q 1119395
2 EX-31.1 inkt-ex31_1.htm EX-31.1 19752
3 EX-31.2 inkt-ex31_2.htm EX-31.2 19936
4 EX-32.1 inkt-ex32_1.htm EX-32.1 13672
  Complete submission text file 0000950170-23-021191.txt   3982972

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inkt-20230331_lab.xml EX-101.LAB 269709
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inkt-20230331_pre.xml EX-101.PRE 187445
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inkt-20230331_def.xml EX-101.DEF 94619
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inkt-20230331.xsd EX-101.SCH 27833
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inkt-20230331_cal.xml EX-101.CAL 23095
40 EXTRACTED XBRL INSTANCE DOCUMENT inkt-20230331_htm.xml XML 540568
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40908 | Film No.: 23910813
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences